Aakanksha Jha

Aakanksha Jha

Auto-generated profile, based on publicly available information

Aakanksha Jha

Fischell Department of Bioengineering, University of Maryland, College Park, MD, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2024 in Trends in Biotechnology
Verified
Journal Article
Closed access
ACAbigail Clevenger
Abigail Clevenger
AJAakanksha Jha
Aakanksha Jha
EMErika Moore
Erika Moore
SRShreya Raghavan
Shreya Raghavan

1 April 2021 in Drug Delivery and Translational Research
Verified
Journal Article
Closed access
PDF file
JSJustin Silberman
Justin Silberman
AJAakanksha Jha
Aakanksha Jha
HRHolly Ryan
Holly Ryan
TATalia Abbate
Talia Abbate
EMErika Moore
Erika Moore

15 February 2024 in Matrix Biology Plus
Verified
Journal Article
Open access
AJAakanksha Jha
Aakanksha Jha
EMErika Moore
Erika Moore
Macrophages are highly plastic immune cells known to exist on a spectrum of phenotypes including pro-inflammatory (M1) or pro-healing (M2). Macrophages interact with extracellular matrix (ECM) ligands, such as fragments of collagen and laminin. Interaction of macrophages with ECM ligands is mediated through integrin receptors. However, the role of ECM ligands in directing macrophage function through integrins is not yet fully understood. Particularly, α2β1 has been implicated in modulating macrophage function, but complexity in mechanisms employed for integrin-ligation especially with laminin-derived peptides makes it challenging to understand macrophage-ECM interactions. We hypothesize that targeting α2β1 through laminin-derived peptide, IKVAV, will modulate macrophage phenotype. In this work we: i) investigated macrophage response to IKVAV in 2D and in a 3D platform, and ii) identified α2β1's role as it pertains to macrophage modulation via IKVAV. Soluble IKVAV treatment significantly reduced M1 markers and increased M2 markers via immunocytochemistry and gene expression. While the 3D ECM-mimicking PEG-IKVAV hydrogels did not have significant effects in modulating macrophage phenotype, we found that macrophage modulation via IKVAV is dependent on the concentration of peptide used and duration of exposure. To investigate integrin-ligand interactions for macrophages, α2β1 signaling was modulated by antagonists and agonists. We observed that blocking α2β1 reduces M1 activation. To understand integrin-ligand interactions and leveraging the therapeutic ability of macrophages in designing immunomodulatory solutions, it is critical to elucidate IKVAV's role in mediating macrophage phenotype.

26 July 2024 in Cellular and Molecular Bioengineering
Verified
Journal Article
Closed access
PDF file
AJAakanksha Jha
Aakanksha Jha
EMErika Moore
Erika Moore

30 July 2026 in Acta Biomaterialia
Verified
Journal Article
Open access
AJAakanksha Jha
Aakanksha Jha
ELElizabeth R. Lawlor
Elizabeth R. Lawlor
CDCole A. DeForest
Cole A. DeForest